Given the potent role of the IL-33/sST2 pathway in murine models of AAA, we hypothesized that circulating sST2 blood levels might be elevated in AAA patients, reflect he advanced AAA disease state and predict the rate of AAA progression [21]. The gene discussed is IL33; the disease is triple-A syndrome.